RECRUITING

Registry of Asthma Characterization and Recruitment 3 (RACR3)

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

Official Title

Registry of Asthma Characterization and Recruitment 3 (RACR3) (CAUSE-02)

Quick Facts

Study Start:2022-04-15

Study Completion:2028-05

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05272241

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:CHILD, ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Participant is either: 1. At least 18 years old, willing and able to provide informed consent at the time of enrollment 2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment 2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)	1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish 2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up 3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study

Inclusion Criteria

Exclusion Criteria

1. Participant is either:
1. At least 18 years old, willing and able to provide informed consent at the time of enrollment
2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)

1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up
3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study

Contacts and Locations

Principal Investigator

Christine A. Sorkness, RPh, PharmD

STUDY_CHAIR

University of Wisconsin School of Medicine and Public Health; Division of Allergy & Immunology

Daniel J. Jackson, MD

STUDY_CHAIR

University of Wisconsin School of Medicine and Public Health; Division of Allergy & Immunology

Study Locations (Sites)

Children's Hospital Colorado: Allergy Program

Aurora, Colorado, 80045

United States

Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site

Washington, District of Columbia, 20010

United States

Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology

Chicago, Illinois, 60611

United States

Boston Children's Hospital: Department of Immunology

Boston, Massachusetts, 02215

United States

Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute

New York, New York, 10029

United States

Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine

New York, New York, 10032

United States

Cincinnati Children's Hospital Medical Center: Asthma Center

Cincinnati, Ohio, 45229

United States

Collaborators and Investigators

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Christine A. Sorkness, RPh, PharmD, STUDY_CHAIR, University of Wisconsin School of Medicine and Public Health; Division of Allergy & Immunology
Daniel J. Jackson, MD, STUDY_CHAIR, University of Wisconsin School of Medicine and Public Health; Division of Allergy & Immunology

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-15

Study Completion Date2028-05

Study Record Updates

Study Start Date2022-04-15

Study Completion Date2028-05

Terms related to this study

Keywords Provided by Researchers

Asthma
Allergy
CAUSE
RACR

Additional Relevant MeSH Terms

Asthma